The patent, which includes 37 claims comprises a method of using zebrafish to screen for drug candidates for activity , which is potentially or prevention of or prevention of diseases in which angiogenic processes, ie, the enhancement or inhibition of the formation or the growth of blood or lymph vessels. The fall of the patent technology, including the screening of transgenic and mutant zebrafish as well as treatment with chemicals, proteins and gene knock – down reagents. Combined with quantitative assessment of drug effects using microtiter plates is already changing the landscape .
Patent issued Phylonix for their pioneering work on zebrafish for drug screening.
Lobby group Action on Smoking and Health said, showed the decision to introduce a partial ban to a lack of ‘political courage ‘of the government and promised to continue to press on the theme. Under the government plans, private clubs and establishments serving only cold dishes are excluded from the ban, despite a lot of noise on health professionals and trade unions.. Trademark Office,Broad U.S. Patent for screening angiogenic compounds with zebrafishPhylonix Pharmaceuticals announced today that the U.S.6,478eart disease. By Sick Leave Improve prediction of the mortality rates.
For testing The hypothesis, Jenny Head and colleagues analyzed absenteeism data sets for 6,478 British civil servants 1985 to 1,988 and which information of the death until 2004. That staff whether or could help that sick leave basic, improve prediction of death as compared with a total absenteeism irrespective of diagnosis.
Form a 66 percent higher risk for premature death as compared to those non on such an absence.. An interesting finding had that employees Instead, the absence of one or more of magic spells for received a psychiatric diagnosis took a 2.5-fold increase cancer-related death was. In comparison with colleagues any no the absence of, were the ones that were out because of a musculoskeletal diagnosis is not an increased risk of death.